BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21432864)

  • 1. Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer.
    Bhusari S; Yang B; Kueck J; Huang W; Jarrard DF
    Prostate; 2011 Nov; 71(15):1621-30. PubMed ID: 21432864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate.
    Fu VX; Dobosy JR; Desotelle JA; Almassi N; Ewald JA; Srinivasan R; Berres M; Svaren J; Weindruch R; Jarrard DF
    Cancer Res; 2008 Aug; 68(16):6797-802. PubMed ID: 18701505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.
    Murata A; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Yoshida N; Oki E; Morita M; Nakao M; Baba H
    Ann Surg Oncol; 2014 Apr; 21(4):1166-74. PubMed ID: 24318096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4.
    Schagdarsurengin U; Lammert A; Schunk N; Sheridan D; Gattenloehner S; Steger K; Wagenlehner F; Dansranjavin T
    Cell Commun Signal; 2017 Oct; 15(1):40. PubMed ID: 29017567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of
    Damaschke NA; Yang B; Bhusari S; Avilla M; Zhong W; Blute ML; Huang W; Jarrard DF
    Cancer Res; 2017 Oct; 77(19):5236-5247. PubMed ID: 28775169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer.
    Zuo QS; Yan R; Feng DX; Zhao R; Chen C; Jiang YM; Cruz-Correa M; Casson AG; Kang XD; Han F; Chen T
    Mol Carcinog; 2011 May; 50(5):390-6. PubMed ID: 21268128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors.
    Bjornsson HT; Brown LJ; Fallin MD; Rongione MA; Bibikova M; Wickham E; Fan JB; Feinberg AP
    J Natl Cancer Inst; 2007 Aug; 99(16):1270-3. PubMed ID: 17686827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway.
    Gao T; He B; Pan Y; Gu L; Chen L; Nie Z; Xu Y; Li R; Wang S
    Clin Transl Oncol; 2014 Apr; 16(4):410-7. PubMed ID: 23943562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer].
    Zhang FR; He XB; Yang YH; Xie W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):31-4. PubMed ID: 12579496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor 2 expression in prostate cancer is regulated by promoter-specific methylation.
    Küffer S; Gutting T; Belharazem D; Sauer C; Michel MS; Marx A; Trojan L; Ströbel P
    Mol Oncol; 2018 Feb; 12(2):256-266. PubMed ID: 29239100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.
    Ravenel JD; Broman KW; Perlman EJ; Niemitz EL; Jayawardena TM; Bell DW; Haber DA; Uejima H; Feinberg AP
    J Natl Cancer Inst; 2001 Nov; 93(22):1698-703. PubMed ID: 11717330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of primary lung cancer in the central China region.
    Zhang M; Wu CH; Zhu XL; Wang YJ
    Asian Pac J Cancer Prev; 2014; 15(18):7799-803. PubMed ID: 25292066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive methylation analysis of imprinting-associated differentially methylated regions in colorectal cancer.
    Hidaka H; Higashimoto K; Aoki S; Mishima H; Hayashida C; Maeda T; Koga Y; Yatsuki H; Joh K; Noshiro H; Iwakiri R; Kawaguchi A; Yoshiura KI; Fujimoto K; Soejima H
    Clin Epigenetics; 2018 Dec; 10(1):150. PubMed ID: 30509319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR.
    Xu W; Fan H; He X; Zhang J; Xie W
    J Exp Clin Cancer Res; 2006 Dec; 25(4):543-7. PubMed ID: 17310846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene.
    Cruz-Correa M; Zhao R; Oviedo M; Bernabe RD; Lacourt M; Cardona A; Lopez-Enriquez R; Wexner S; Cuffari C; Hylind L; Platz E; Cui H; Feinberg AP; Giardiello FM
    Epigenetics; 2009 Feb; 4(2):114-8. PubMed ID: 19242102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypomethylation of the IGF2 DMR in colorectal tumors, detected by bisulfite pyrosequencing, is associated with poor prognosis.
    Baba Y; Nosho K; Shima K; Huttenhower C; Tanaka N; Hazra A; Giovannucci EL; Fuchs CS; Ogino S
    Gastroenterology; 2010 Dec; 139(6):1855-64. PubMed ID: 20682317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues.
    Zhao R; DeCoteau JF; Geyer CR; Gao M; Cui H; Casson AG
    Carcinogenesis; 2009 Dec; 30(12):2117-22. PubMed ID: 19843644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site.
    Ulaner GA; Vu TH; Li T; Hu JF; Yao XM; Yang Y; Gorlick R; Meyers P; Healey J; Ladanyi M; Hoffman AR
    Hum Mol Genet; 2003 Mar; 12(5):535-49. PubMed ID: 12588801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer.
    Ito Y; Koessler T; Ibrahim AE; Rai S; Vowler SL; Abu-Amero S; Silva AL; Maia AT; Huddleston JE; Uribe-Lewis S; Woodfine K; Jagodic M; Nativio R; Dunning A; Moore G; Klenova E; Bingham S; Pharoah PD; Brenton JD; Beck S; Sandhu MS; Murrell A
    Hum Mol Genet; 2008 Sep; 17(17):2633-43. PubMed ID: 18541649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.
    Murphy SK; Huang Z; Wen Y; Spillman MA; Whitaker RS; Simel LR; Nichols TD; Marks JR; Berchuck A
    Mol Cancer Res; 2006 Apr; 4(4):283-92. PubMed ID: 16603642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.